Independent register of U.S. FDA drug recalls · updated Oct 11, 2026
RxRecalls Get alerts

FDA Drug Recalls

18,003 recalls, newest first

Class I · High risk

Morphine Sulfate extended-Release Tablets

Labeling: Label Mix-up: bottles labeled as Morphine Sulfate 60 mg Extended-Release tablets contain Morphine Sulfate 30 mg Extended-Release tablets and bottles labeled as Morphine Sulfate 30 mg Extended-Release tablets may contain Morphine Sulfate 60 mg Extended-Release tablets.

Terminated Labeling / mix-up Bryant Ranch Prepack, Inc. NDC 63629-1089-01 D-1188-2022
Class I · High risk

Morphine Sulfate extended-Release Tablets

Labeling: Label Mix-up: bottles labeled as Morphine Sulfate 60 mg Extended-Release tablets contain Morphine Sulfate 30 mg Extended-Release tablets and bottles labeled as Morphine Sulfate 30 mg Extended-Release tablets may contain Morphine Sulfate 60 mg Extended-Release tablets.

Terminated Labeling / mix-up Bryant Ranch Prepack, Inc. D-1187-2022
Class II · Moderate risk

Draximage MAA

Lack of Assurance of Sterility: Out-of-specification test results obtained for Endotoxin testing.

Terminated Sterility / contamination Jubilant Draximage Inc NDC 65174-270-30 D-1189-2022
Class II · Moderate risk

Eszopiclone Tablets

Shortfill: customer complaints of one to three tablets were reported missing from 30 count bottles.

Terminated Failed specification Macleods Pharma Usa Inc NDC 33342-299-07 D-1174-2022
Class II · Moderate risk

70% ISOPROPYL ALCOHOL First aid antiseptic

Defective Container: Product may leak when squeezed or when not in an upright position determined to be due to defects in the bottle neck finish and insufficient tightening.

Terminated Packaging defect Vi-Jon, LLC D-1151-2022
Class II · Moderate risk

Tretinoin Capsules

Failed Dissolution Specifications; Low Out of Specification (OOS) results for dissolution.

Terminated Dissolution failure Teva Pharmaceuticals USA Inc NDC 0555-0808-02 D-1156-2022

Recalls by year